Investigations on recyclisation and hydrolysis in avibactam mediated serine β-lactamase inhibition
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigations on recyclisation and hydrolysis in avibactam mediated serine β-lactamase inhibition
Authors
Keywords
-
Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 14, Issue 17, Pages 4116-4128
Publisher
Royal Society of Chemistry (RSC)
Online
2016-04-13
DOI
10.1039/c6ob00353b
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition
- (2015) Dustin T. King et al. ACS Infectious Diseases
- Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48
- (2014) Sushmita D. Lahiri et al. ACS Chemical Biology
- Inactivation of TEM-1 by Avibactam (NXL-104): Insights from Quantum Mechanics/Molecular Mechanics Metadynamics Simulations
- (2014) Jacopo Sgrignani et al. BIOCHEMISTRY
- The chemistry and biological potential of azetidin-2-ones
- (2014) Nikhilesh Arya et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Binding of (5S)-Penicilloic Acid to Penicillin Binding Protein 3
- (2013) Sander S. van Berkel et al. ACS Chemical Biology
- Structural Origins of Oxacillinase Specificity in Class D β-Lactamases
- (2013) Cynthia M. June et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases
- (2013) Sushmita D. Lahiri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotics in the clinical pipeline in 2013
- (2013) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial
- (2013) Christopher Lucasti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Crystal Structures of Yellowtail Ascites Virus VP4 Protease
- (2013) Ivy Yeuk Wah Chung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
- (2013) David E. Ehmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanism of Acyl–Enzyme Complex Formation from the Henry–Michaelis Complex of Class C β-Lactamases with β-Lactam Antibiotics
- (2013) Ravi Tripathi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
- (2012) José A. Vazquez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Improving known classes of antibiotics: an optimistic approach for the future
- (2012) Karen Bush CURRENT OPINION IN PHARMACOLOGY
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
- (2011) Ken Coleman CURRENT OPINION IN MICROBIOLOGY
- Metallo-β-lactamases: a last frontier for β-lactams?
- (2011) Giuseppe Cornaglia et al. LANCET INFECTIOUS DISEASES
- Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non- -Lactam -Lactamase Inhibitor
- (2010) T. Stachyra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Bridging cell wall biosynthesis and bacterial morphogenesis
- (2010) Pierre-Jean Matteï et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Current Challenges in Antimicrobial Chemotherapy
- (2010) Carine Bebrone et al. DRUGS
- Structural Basis for the Interaction of Lactivicins with Serine β-Lactamases
- (2010) Tom Brown et al. JOURNAL OF MEDICINAL CHEMISTRY
- Updated Functional Classification of -Lactamases
- (2009) K. Bush et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of the -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
- (2009) T. Stachyra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Systematic optimization of long-range corrected hybrid density functionals
- (2008) Jeng-Da Chai et al. JOURNAL OF CHEMICAL PHYSICS
- Investigation of the Mechanism of the Cell Walldd-Carboxypeptidase Reaction of Penicillin-Binding Protein 5 ofEscherichia coliby Quantum Mechanics/Molecular Mechanics Calculations
- (2008) Qicun Shi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started